scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Nasri H | |
Rafieian-Kopaei M | |||
P2860 | cites work | Metformin: An Update | Q22241145 |
Metformin: new understandings, new uses | Q22241434 | ||
The management of gestational diabetes | Q22241441 | ||
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug? | Q22241958 | ||
Drugs for anovulatory infertility in polycystic ovary syndrome | Q22242103 | ||
Clomiphene citrate, metformin or both as first-step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS): a systematic review of head-to-head randomized controlled studies and meta-analysis | Q22242629 | ||
Consensus on infertility treatment related to polycystic ovary syndrome | Q22242888 | ||
Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review | Q22252361 | ||
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility | Q24240501 | ||
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus | Q24240522 | ||
Comparison of metformin and insulin in the treatment of gestational diabetes: a retrospective, case-control study | Q24642229 | ||
Catastrophic antiphospholipid syndrome: a clinical review | Q27009935 | ||
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
Metformin and reduced risk of cancer in diabetic patients | Q29616275 | ||
ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. | Q30486653 | ||
Diabetic nephropathy and antioxidants. | Q30486658 | ||
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline | Q33587845 | ||
Lactic acidosis induced by metformin: incidence, management and prevention | Q33654578 | ||
A risk-benefit assessment of metformin in type 2 diabetes mellitus | Q33678321 | ||
World Kidney Day 2014: increasing awareness of chronic kidney disease and aging | Q42019457 | ||
Acute kidney injury and renal angina | Q42056454 | ||
World diabetes day; 2013. | Q42749014 | ||
The mechanism of insulin resistance caused by HIV protease inhibitor therapy. | Q42802122 | ||
Acute kidney injury and beyond | Q42956075 | ||
Ginger and diabetic nephropathy | Q42956114 | ||
Renoprotective effects of garlic | Q42956125 | ||
Preventive role of erythropoietin against aminoglycoside renal toxicity induced nephropathy; current knowledge and new concepts | Q42956132 | ||
Protection of renal tubules against gentamicin induced nephrotoxicity | Q42956136 | ||
On the occasion of the world diabetes day 2013; diabetes education and prevention; a nephrology point of view | Q42956148 | ||
Novel renoprotection methods by local and remote conditioning. | Q42956293 | ||
Antioxidant and kidney protection; differential impacts of single and whole natural antioxidants | Q42956305 | ||
Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study | Q43285625 | ||
Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines | Q43687476 | ||
Contra-indications to metformin therapy are largely disregarded | Q44001864 | ||
Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study | Q44820677 | ||
Comparison of morphine and tramadol effects on phagocytic activity of mice peritoneal phagocytes in vivo. | Q46053665 | ||
Metformin delays the manifestation of diabetes and vascular dysfunction in Goto-Kakizaki rats by reduction of mitochondrial oxidative stress | Q46917685 | ||
The structure of human mitochondrial DNA variation. | Q53853320 | ||
Metformin-induced AMP-activated protein kinase activation regulates phenylephrine-mediated contraction of rat aorta. | Q54515630 | ||
Metformin improves diabetic kidney disease. | Q54998981 | ||
Oxidative damage to mitochondrial DNA and its relationship to diabetic complications | Q73250565 | ||
Contraindications to metformin therapy in patients with NIDDM | Q73374774 | ||
Effects of metformin on insulin resistance and central adiposity in patients receiving effective protease inhibitor therapy | Q77889220 | ||
Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome | Q80535497 | ||
Metformin and lactic acidosis | Q82825092 | ||
Pharmacokinetics of metformin during pregnancy | Q33861891 | ||
Mysterious metformin | Q34087853 | ||
Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes? | Q34323195 | ||
Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients | Q34385733 | ||
Histopathological study of the combination of metformin and garlic juice for the attenuation of gentamicin renal toxicity in rats | Q34385766 | ||
Teucrium polium and kidney | Q34385787 | ||
Effect of Salvia officinalis on diabetic patients | Q34385848 | ||
Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial | Q34385921 | ||
Polycystic ovary syndrome: a new direction in treatment. | Q34484562 | ||
Metformin use and mortality among patients with diabetes and atherothrombosis | Q34625337 | ||
Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats | Q34782590 | ||
Antidiabetic therapies affect risk of pancreatic cancer | Q34976430 | ||
Drug treatments for polycystic ovary syndrome | Q34978542 | ||
Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia | Q35601616 | ||
Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin | Q36302667 | ||
Metformin therapy and clinical uses | Q37262966 | ||
New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes | Q37319178 | ||
Chronic kidney disease in children: A report from a tertiary care center over 11 years | Q37455044 | ||
Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues | Q37455085 | ||
Effects of N-acetyl cysteine on serum lipoprotein (a) and proteinuria in type 2 diabetic patients. | Q37455129 | ||
Association of serum calcium with level of blood pressure in type 2 diabetic patients. | Q37476096 | ||
Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized, double-blind, placebo controlled clinical trial | Q37642071 | ||
Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes | Q38092988 | ||
Diabetes and pregnancy: an endocrine society clinical practice guideline | Q38160216 | ||
Complexity of diabetic nephropathy pathogenesis and design of investigations | Q38262136 | ||
The definition and detection of acute kidney injury | Q38262138 | ||
Impact of Momordica charantia extract on kidney function and structure in mice. | Q38305388 | ||
Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. | Q38464449 | ||
Correlation between antioxidant activity of garlic extracts and WEHI-164 fibrosarcoma tumor growth in BALB/c mice. | Q39495861 | ||
Metformin induces suppression of NAD(P)H oxidase activity in podocytes. | Q39745297 | ||
Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria | Q40082378 | ||
The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats | Q40108320 | ||
Antioxidant supplementation in hypertension | Q41826687 | ||
Comment on: Serum cholesterol and LDL-C in association with level of diastolic blood pressure in type 2 diabetic patients | Q41840917 | ||
A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin-induced toxicity in animal model? | Q41861324 | ||
Epidemiology of chronic kidney disease in children | Q41861328 | ||
Prediction of diabetic nephropathy: The need for a sweet biomarker | Q41861391 | ||
Plants antioxidants: From laboratory to clinic. | Q41870485 | ||
Combination of metformin with other antioxidants may increase its renoprotective efficacy | Q41877909 | ||
Toxic renal injury at a glance | Q41984415 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | metformin | Q19484 |
P304 | page(s) | 658-64 | |
P577 | publication date | 2014-07-01 | |
P1433 | published in | Journal of Research in Medical Sciences | Q15816632 |
P1476 | title | Metformin: Current knowledge | |
P478 | volume | 19 |
Q90713975 | 3'-Sialyllactose prebiotics prevents skin inflammation via regulatory T cell differentiation in atopic dermatitis mouse models |
Q92146864 | A more physiological approach to lipid metabolism alterations in cancer: CRC-like organoids assessment |
Q58691643 | Association of metformin administration with gut microbiome dysbiosis in healthy volunteers |
Q37097171 | Black ginger extract increases physical fitness performance and muscular endurance by improving inflammation and energy metabolism |
Q47095883 | Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats |
Q58618227 | Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study |
Q26781169 | Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome |
Q89939659 | Guidelines and Considerations for Metabolic Tolerance Tests in Mice |
Q42092734 | Inhibition of P-glycoprotein expression and function by anti-diabetic drugs gliclazide, metformin, and pioglitazone in vitro and in situ |
Q90477339 | Insulinotropic Activity of Standardized Methanolic Extracts of Ficus deltoidea from Seven Varieties |
Q59796733 | Metformin ameliorated methotrexate-induced hepatorenal toxicity in rats in addition to its antitumor activity: two birds with one stone |
Q38695966 | Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes |
Q98619283 | Metformin as a Potential Agent in the Treatment of Multiple Sclerosis |
Q90198885 | Metformin limits osteoarthritis development and progression through activation of AMPK signalling |
Q55129722 | Nightmare and Abnormal Dreams: Rare Side Effects of Metformin? |
Q92155249 | Non-Alcoholic Fatty Liver Disease, an Overview |
Q58597585 | Oriental herbal medicine and moxibustion for polycystic ovary syndrome: A meta-analysis |
Q90343874 | Perioperative metformin: Friend or foe |
Q52603694 | Pharmacological Agents Utilized in Patients With Type-2 Diabetes: Beyond Lowering A1c. |
Q49949624 | Short-term treatment with metformin reduces hepatic lipid accumulation but induces liver inflammation in obese mice |
Q58753496 | The NOAEL Metformin Dose Is Ineffective against Metabolic Disruption Induced by Chronic Cadmium Exposure in Wistar Rats |
Q92935057 | The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus |
Q36908331 | The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers. |
Q38334922 | Treatment of clozapine-associated weight gain: a systematic review. |
Search more.